Skip to main content

Table 1 Distribution of patients’ general characteristics in the intervention group and control group

From: The evaluation of cognitive-behavioral therapy-based intervention on type 2 diabetes patients with comorbid metabolic syndrome: a randomized controlled trial

Variables

Total

Intervention

(N = 148)

Control

(N = 133)

T/χ2

P

Age

49.91 ± 11.84

47.66 ± 12.31

52.41 ± 10.80

− 3.423

0.001

Gender

   

0.734

0.392

 Female

113(40.20)

56(49.60)

57(50.40)

  

 Male

168(59.80)

92(54.80)

76(45.20)

  

Marriage

  

5.289

0.071

 Unmarried

16(5.70)

12(75.00)

4(25.00)

  

 Married with a spouse

255(90.70)

133(52.20)

122(47.80)

  

 Divorced

10(3.60)

3(30.00)

7(70.00)

  

Education

  

7.517

0.023

 Junior high school and below

116(41.30)

50(43.10)

66(56.90)

  

 High school or junior college

92(32.70)

53(57.60)

39(42.40)

  

 College and above

73(26.00)

45(61.60)

28(38.40)

  

Monthly income (RMB)

  

2.352

0.308

  < 5000

97(34.50)

47(48.50)

50(51.50)

  

 5000–10,000

95(33.80)

56(58.90)

39(41.10)

  

  > 10,000

89(31.70)

45(50.60)

44(49.40)

  

Smoke

   

0.860

0.354

 No

212(75.40)

115(54.20)

97(45.80)

  

 Yes

69(24.60)

33(47.80)

36(52.20)

  

Drink

   

0.603

0.438

 No

184(65.50)

100(54.30)

84(45.70)

  

 Yes

97(34.50)

48(49.50)

49(50.50)

  

Treatment

  

2.104

0.349

 Oral medicine

90(32.00)

53(58.90)

37(41.10)

  

 Oral medicine and insulin

35(12.50)

18(51.40)

17(48.60)

  

 Oral medicine and GLP1

156(55.50)

77(49.40)

79(50.60)

  

Years of diabetes

  

3.603

0.058

  ≤ 5

189(67.30)

107(56.60)

82(43.40)

  

  > 5

92(32.70)

41(44.60)

51(55.40)

  

Complications

  

6.098

0.014

 No

215(76.50)

122(56.70)

93(43.30)

  

 Yes

66(23.50)

26(39.40)

40(60.60)

  

Depression (Score)

3.78 ± 3.88

4.11 ± 4.35

3.40 ± 3.26

1.548

0.123

Anxiety (Score)

2.46 ± 3.51

2.76 ± 3.86

2.13 ± 3.04

1.540

0.125

SDSCA (Score)

26.33 ± 12.91

26.79 ± 12.18

25.82 ± 13.71

0.629

0.530

SF12 (Score)

72.24 ± 13.37

72.49 ± 12.93

71.95 ± 13.88

0.341

0.733

PSQI (Score)

6.63 ± 3.28

6.22 ± 3.21

7.08 ± 3.31

− 2.228

0.027

Diabetes knowledge (Score)

4.72 ± 2.25

5.07 ± 2.19

4.32 ± 2.26

2.829

0.005

Efficacy of CBT (Score)

47.11 ± 6.88

47.45 ± 6.83

46.74 ± 6.94

0.862

0.389

BMI (kg/m2)

27.13 ± 3.14

27.16 ± 3.43

27.10 ± 2.81

0.147

0.883

SBP (mmHg)

137.54 ± 16.79

138.04 ± 17.37

136.98 ± 16.17

0.523

0.602

DBP (mmHg)

82.04 ± 10.66

82.88 ± 11.48

81.10 ± 9.63

1.414

0.158

HbA1c (%)

7.38 ± 1.70

7.36 ± 1.59

7.40 ± 1.82

− 0.172

0.863

FPG (mmol/L)

8.20 ± 3.30

8.16 ± 2.62

8.25 ± 3.94

− 0.248

0.804

TG (mmol/L)

2.07 ± 1.80

2.06 ± 1.84

2.07 ± 1.75

− 0.050

0.960

TC (mmol/L)

4.90 ± 1.33

4.85 ± 1.30

4.96 ± 1.37

− 0.665

0.507

HDL-C (mmol/L)

1.18 ± 0.24

1.14 ± 0.22

1.21 ± 0.27

− 2.418

0.016

LDL-C (mmol/L)

3.08 ± 0.96

3.08 ± 0.92

3.08 ± 1.00

− 0.002

0.998

  1. RMB Ren min bi, GLP-1RA Glp-1 receptor agonist, SDSCA Summary of Diabetes Self-Care Activities, CBT Cognitive behavioral therapy, SF12 Short Form 12, PSQI Pittsburgh Sleep Quality Index, BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, HbA1c Glycated hemoglobin, FPG Fasting plasma glucose, TG Triglycerides, TC Total cholesterol, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol